HUMA

Humacyte, Inc.

Healthcare · Biotechnology

$92.93 sample

-1.31 (-1.39%) 1D

Market cap

$528.3B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-29

Alerts

8

Price$92.93 -16.26% 3M daily closessample

110.9891.82

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29SECDEF 14A filed
Sep 24INSInsider sell: Director
Sep 17INSInsider buy: Director
Sep 08SECForm 144 filed
Sep 02INSInsider sell: General Counsel
Aug 26INSInsider buy: Chief Executive Officer
Aug 19SEC8-K filed: material event
Aug 14INSInsider sell: Director

Sign up to see the real HUMA record →

Company facts

SEC EDGAR registration

Name: Humacyte, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +55sample, -100 to +100
Reporting currency: USD

Who is positioning in HUMA

sample

Insiders: 11 insider transactions over 90 days, net selling, $772.5M
Congress: 3 members traded over 90 days
Institutions · 13F: 18 funds hold $4.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.5B +16.7% y/y

Q4 2024Q3 2026

Inventory$11.4B +20.4% y/y

Q4 2024Q3 2026

Accounts receivable$8.4B +20.0% y/y

Q4 2024Q3 2026

Total debt$21.0B +12.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $521.3B +0.4% 3M
Sample peer B: $337.5B +15.4% 3M
Sample peer C: $400.3B +11.3% 3M
Sample peer D: $264.1B +8.4% 3M
Sample peer E: $523.7B -4.7% 3M